Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
Publications search results
TitlePublishedTypeProducts
Development of a network of carcinogenicity adverse outcome pathways and its employment as an evidence framework for safety assessmentKaptis
Application of AOPs for Weight-of-Evidence Assessments: Rationalising Evidence for the ICH S1B(R1) Guidance Addendumpdf fileKaptis
Interrogating AOP-Wiki knowledge as a networkpdf fileKaptis
Using adverse outcome pathways to contextualise (Q)SAR predictions for reproductive toxicity – A case study with aromatase inhibitionKaptis
Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendumKaptis
Could the Lhasa Cloud be the best hosting option for you? (Infographic)pdf fileMirabilisViticKaptis
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - SOT 2021 Presentation Slidespdf fileKaptisDerek Nexus
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - PETA Science Consortium Webinar Slidespdf fileKaptis
Bringing Together Scientific Disciplines for Collaborative Undertakings: A Vision for Advancing the Adverse Outcome Pathway Frameworkpdf fileKaptis
Beyond adverse outcome pathways: making toxicity predictions from event networks, SAR models, data and knowledgeKaptis
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Riskpdf fileKaptis
Application of adverse outcome pathways (AOPs) to support genotoxicity assessmentpdf fileKaptis
Session 2 - Integration of adverse outcome pathways with experimental data to support the assessment of carcinogenic risk - Slidespdf fileKaptis
Session 2 - Integration of adverse outcome pathways with experimental data to support the assessment of carcinogenic risk - RecordingKaptis
Linking Evidence With AOPs To Produce Integrated Approaches to Testing and Assessment (IATA)pdf fileKaptis
Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental Data_EMGS Data Challenge 2020pdf fileKaptisDerek NexusVitic
The Application of Adverse Outcome Pathways (AOPs) for Risk Assessmentpdf fileKaptis
The application of in silico models to support decision making in toxicologypdf fileDerek NexusSetariaViticZenethMirabilisSarah NexusEffirisKaptis
Utilising Adverse Outcome Pathways as a Framework to Organise Evidence and Support Carcinogenicity Risk Assessmentpdf fileKaptis
Predicting the safety of medicines in pregnancy: A workshop reportKaptis
Future Developments AOP Networks And Predicting Secondary Pharmacologypdf fileEffirisKaptis
Carcinogenicity Adverse Outcome Pathwayspdf fileDerek NexusKaptisVitic
Product Update 2019pdf fileDerek NexusSarah NexusZenethViticSetariaMirabilisMeteor NexusLhasa Carcinogenicity DatabaseKaptisEffiris
A Case Study in Predicting hERG Activity.Derek NexusSarah NexusMirabilisMeteor NexusKaptisEffirisViticZenethSetaria
Developing AOP Networks and Making them Usefulpdf fileKaptis

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.